Update on antiviral therapy for genital herpes infection

Cleveland Clinic Journal of Medicine

Volumn 67, Issue 8, 2000, Pages 567-573

  Geers, Teresa A ^b   Isada, Carlos M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; FAMCICLOVIR; FOSCARNET; FOSCARNET SODIUM; VALACICLOVIR;

GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; INFECTION RISK; PATIENT COUNSELING; RECURRENT INFECTION; REVIEW; SEXUAL TRANSMISSION; SIDE EFFECT; VIRUS SHEDDING;

EID: 0033853063     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.67.8.567     Document Type: Review

References (17)

1. Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR 1998; 47(RR-1):20-26.
2. Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral isolation procedures. N Engl J Med 1992; 326:1533-1539.
3. Ashley RL. Genital herpes-type-specific antibodies for diagnosis and management. Sex Transm Dis 1998; 16:789-793.
4. Tyring SK, Carlton SS, Evans T. Herpes - Atypical clinical manifestations. Sex Transm Dis 1998; 16:783-788.
5. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994; 121:847-854.
6. Koelle DM, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes Ann Intern Med 1992; 116:433-437.
7. Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999; 131:14-20.
8. Wald A. Herpes - Transmission and viral shedding. Sex Transm Dis 1998; 16:795-797.
9. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333:770-775.
10. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996; 124:8-15.
11. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women - effect of acyclovir treatment. J Clin Invest 1997; 99:1092-1097.
12. Clark JL, Tatum NO. Management of genital herpes. Am Fam Phys 1995; 51:175-183.
13. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections. Clinical manifestations, course and complications. Ann Intern Med 1983; 98:958-972.
14. Flores PA, Longworth DL. The new non-HIV antivirals and antifungals: review and assessment for the formulary. Formulary 1997; 32:386-346.
15. Hitchcock MJM, Jaffe HS, Martin JC, Stagg RJ. Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral Chemistry and Chemotherapy 1996; 7:115-127.
16. Spruance SL, Tyring SK, DeGregorio B, Miller C, Beutner KB. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group. Arch Intern Med 1996; 156:1729-1735.
17. Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL. Oral famciclovir for the suppression of recurrent genital herpes - A randomized controlled trial. JAMA 1998; 280:887-892.